Table 3 Total scores of knowledge questions (SCIP Section2) classified into specific smoking-related themes
From: Smoking cessation in community pharmacy practice–a clinical information needs analysis
Total knowledge score (%) | ||||
|---|---|---|---|---|
Knowledge section (32 items) categories | Pharmacy students (A) | Pharmacists (B) | Smoking educators (C) | ANOVA post hoc significance |
Epidemiology (3Qs) | 54% ± 24.5 | 54.3% ± 29 | 81.7% ± 22.9 | A < B < C: P < .001 |
A vs B: P > .05 | ||||
A vs C: P < .05 | ||||
B vs C: P < .05 | ||||
Adverse effects of smoking (3Qs) | 91.7% ± 16 | 92% ± 14.3 | 90% ± 15.7 | A < B < C: P = .873 |
A vs B: P > .05 | ||||
A vs C: P > .05 | ||||
B vs C: P > .05 | ||||
Forms of tobacco smoking (2Qs) | 86% ± 26.9 | 85.5% ± 27 | 100% | A < B < C: P = .068 |
A vs B: P > .05 | ||||
A vs C: P < .05 | ||||
B vs C: P < .05 | ||||
Cigarette constituents (2Qs) | 91% ± 20.3 | 85.5% ± 23 | 87.5% ± 22.2 | A < B < C: P = .180 |
A vs B: P > .05 | ||||
A vs C: P > .05 | ||||
B vs C: P > .05 | ||||
Pharmacology of dependence (4Qs) | 75.3% ± 22.6 | 80.5% ± 18.3 | 87.5% ± 17.2 | A < B < C: P = .025 |
A vs B: P > .05 | ||||
A vs C: P < .05 | ||||
B vs C: P > .05 | ||||
Assessment of Dependence (3Qs) | 43% ± 27.6 | 43% ± 26.1 | 56.7% ± 21.9 | A < B < C:P = .092 |
A vs B: P > .05 | ||||
A vs C: P < .05 | ||||
B vs C: P < .05 | ||||
Pharmacotherapy (15Qs) | 53.8% ± 14.1 | 57% ± 15.9 | 72% ± 10.9 | A < B < C: P < .001 |
A vs B: P > .05 | ||||
A vs C: P < .05 | ||||
B vs C: P < .05 | ||||